Cargando…
Personalized radioiodine therapy for thyroid cancer patients with known disease
Radioactive iodine (RAI) (131)I is a targeted therapy for patients with RAI-avid follicular cell-derived thyroid cancer. However, the responsiveness to (131)I therapy varies among thyroid cancer patients mainly owing to differential RAI uptake and RAI radiosensitivity among patients’ lesions. A pers...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Faculty Opinions Ltd
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8103907/ https://www.ncbi.nlm.nih.gov/pubmed/33977289 http://dx.doi.org/10.12703/r/10-36 |